[1]
Govindapala, D., Dhanaratna, D., Senarath, U., Lamabadusuriya, D., Senaratne, T., Wijenayake, W., Wijewardena, D., Nakkawita, D., Kawyangana, P., Kulasekara, U., De Silva, A.D. and Fernando, N. 2022. Reactogenicity and persistence of IgG antibodies against SARS-CoV-2 among recipients of ChAdOx1 nCoV-19 vaccine: A single center experience from Sri Lanka. International Journal of Health Sciences. 17, 1 (Dec. 2022), 36–43.